Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants

Recruiting N/A Interventional Study
Bronchopulmonary Dysplasia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
0 Hours – 1
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
50 (estimated)
Sponsor
Boston Children's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to determine if postpyloric feedings effectively improve objective measures of pulmonary health in preterm infants with chronic lung disease when compared with nasogastric (NG) feedings. This research will (1) determine the optimal nutritional management to prevent a common and costly complication of prematurity, and (2) use a novel crossover design that examines outco…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Preterm infants born \< 32 weeks' gestation may enroll at 34-44 weeks post-menstrual age, who: 1. Remain on either invasive ventilation or non-invasive ventilation (continuous positive airway pressure or nasal intermittent positive pressure ventilation) for minimum 48 hours at …
Contacts

Jonathan Levin, MD

617-355-1900

jonathan.levin@childrens.harvard.edu

CONTACT

Vanessa J Young, MS

617-355-8330

vanessa.young@childrens.harvard.edu

CONTACT